Cargando…
The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes
Objective. Sclerostin is a Wnt inhibitor produced specifically by osteocytes. However, it is not currently clear whether renal dysfunction has an effect on circulating sclerostin level in patients with type 2 diabetes. The aim of the study was to evaluate this relationship. Design and Patients. We c...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099222/ https://www.ncbi.nlm.nih.gov/pubmed/25053944 http://dx.doi.org/10.1155/2014/715908 |